Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Pixel circuit
Optical packet signal transmission device and WDM optical communication network
Washing machine
Autonomous downlink code selection for femto cells
Data recording apparatus with recording control based on defect block and control method thereof
Image processing apparatus, image display apparatus, and image processing method
Treatment of influenza
  Randomly Featured Patents
Method, device and system for generating and receiving a phase polarization modulated signal
Process for preparing pulverulent coating composition based upon polyamide having at least 10 aliphatically bound carbon atoms per carbonamide group
Semiconductor device consisting of a semiconductor material having a deep impurity level
Determining the concentration of additives in petroleum fuels
Method for loading tube bundles on railcars and tube packs for railcars
Polyaniline compositions having a surface/core dopant arrangement
Communication channel with undersampled interpolative timing recovery
Telephone line interface circuit
Automated bubble trap
Superconducting induction apparatus